These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28499649)

  • 1. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
    Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
    Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis.
    Vogel TJ; Jeon C; Karlan B; Walsh C
    Gynecol Oncol; 2016 Feb; 140(2):285-8. PubMed ID: 26691221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
    Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
    Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer outcomes: Predictors of early death.
    Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
    Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer.
    Wright JD; Ananth CV; Tsui J; Glied SA; Burke WM; Lu YS; Neugut AI; Herzog TJ; Hershman DL
    Cancer; 2014 Apr; 120(8):1246-54. PubMed ID: 24443159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
    Gockley A; Melamed A; Bregar AJ; Clemmer JT; Birrer M; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Obstet Gynecol; 2017 Mar; 129(3):439-447. PubMed ID: 28178043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008.
    Lin JJ; Egorova N; Franco R; Prasad-Hayes M; Bickell NA
    Obstet Gynecol; 2016 Jan; 127(1):81-89. PubMed ID: 26646132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin intake is associated with better survival in ovarian cancer: a case-control study.
    Kumar S; Meuter A; Thapa P; Langstraat C; Giri S; Chien J; Rattan R; Cliby W; Shridhar V
    Cancer; 2013 Feb; 119(3):555-62. PubMed ID: 23208739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year relative survival for epithelial ovarian cancer.
    Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
    Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population.
    Forde GK; Chang J; Ziogas A; Tewari K; Bristow RE
    Gynecol Oncol; 2015 Jun; 137(3):479-84. PubMed ID: 25866323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study.
    Gallotta V; Petrillo M; Conte C; Vizzielli G; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Carbone V; Scambia G
    J Minim Invasive Gynecol; 2016; 23(5):769-74. PubMed ID: 26995493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
    Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
    Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.